IMNM R&D Expense Growth

Immunome Inc · R&D Expense Growth

IMNM logo

IMNM R&D Expense Growth

Latest reported34.57%
IMNM FY R&D Growth (YoY) (0.00% → 34.57%)
High-resolution chart · PNG

IMNM r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
34.5749%
461.055%
-0.7864%
64.9327%
109.6271%
-23.7108%
28.2972%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.